Senti Biosciences

Tim Lu, M.D., Ph.D., Co-Founder and CEO
San Francisco, CA
Senti Biosciences is a next-generation therapeutics company that is developing gene circuits and programming cells for tremendous therapeutic value. Senti’s mission is to outsmart complex diseases with more intelligent medicines that will transform people’s lives. By programming cells to respond, adapt, and make decisions, Senti is creating smarter therapies with computer-like logic, enhanced functionality, and greater therapeutic control. Senti’s product candidates are designed to address major challenges in cancer treatment by equipping them with gene circuits that allow them to overcome cancer immune evasion, and more precisely target and eliminate cancer cells while sparing healthy tissue. Senti Biosciences is based in South San Francisco and was founded in 2016 by Drs. Tim Lu, Philip Lee, Jim Collins, and Wilson Wong. Senti is proud to count NEA, 8VC, Amgen Ventures, Lux Capital, Menlo Ventures, Pear Ventures, Allen & Company, Nest.Bio, Omega Funds, and LifeForce Capital among its investors.

By using this website you agree to accept our Privacy Policy and Terms & Conditions